cyproterone acetate has been researched along with Carcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumanov, Kh; Tsvetkov, M | 1 |
| Kumanov, Kh; Mladenov, D; Tsvetkov, M | 1 |
| Atahan, O; Kayigil, O; Metin, A | 1 |
| de Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, U; Sylvester, R | 1 |
| Bosland, MC; Johnson, WD; Kelloff, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Gobet, DA; Hauri, D; Knönagel, H | 1 |
| Boronat, F; Broseta, E; Gallego, J; Jiménez-Cruz, JF; Llopis, B; Osca, JM | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S | 1 |
| al-Abadi, H; Borgmann, V; Nagel, R | 1 |
| Bruchovsky, N; Coppin, CM; Goldenberg, SL; Rennie, PS | 1 |
| Bollack, C; Rougeron, G | 1 |
1 review(s) available for cyproterone acetate and Carcinoma
| Article | Year |
|---|---|
[Volumetric and structural changes of prostatic carcinoma under hormonal treatment].
Topics: Aged; Aged, 80 and over; Carcinoma; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Ultrasonography | 1990 |
4 trial(s) available for cyproterone acetate and Carcinoma
| Article | Year |
|---|---|
Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis o
Topics: Acid Phosphatase; Administration, Intranasal; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Cause of Death; Cyproterone Acetate; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Subcutaneous; Male; Middle Aged; Orchiectomy; Pain Measurement; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological
Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
Topics: Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Random Allocation | 1988 |
Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Buserelin; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Cytophotometry; DNA, Neoplasm; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Remission Induction | 1988 |
7 other study(ies) available for cyproterone acetate and Carcinoma
| Article | Year |
|---|---|
[Clinical studies in prostatic carcinoma].
Topics: Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Cyproterone Acetate; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostatectomy; Prostatic Neoplasms; Remission Induction | 1993 |
[The treatment of prostatic carcinoma with cyproterone acetate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cyproterone Acetate; Drug Evaluation; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1996 |
Cyproterone acetate monotherapy in advanced prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carcinoma; Cyproterone Acetate; Disease Progression; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Testosterone; Treatment Outcome | 1997 |
Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinoma; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Male; Methylnitrosourea; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Time Factors | 1999 |
Endocrine treatment prior to radical retropubic prostatectomy in patients with T3 prostate cancer: a retrospective study of 22 patients.
Topics: Aged; Biopsy; Carcinoma; Combined Modality Therapy; Cyproterone Acetate; Humans; Male; Neoplasm Recurrence, Local; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Time Factors; Triptorelin Pamoate | 1992 |
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Evaluation; Drug Synergism; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Testosterone | 1988 |
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1988 |